Jess, that's a good point.
However, as this is head to head vs. Restasis, I would suggest that mediocre results would be if it only got equivalent results. Because VOS is similar in action, but is four times more concentrated, I would be surprised if it didn't surpass Restasis.
If only achieves equivalent results, would still be a viable competitor, and potential licensing candidate.
Having seen how the share price moves on little or no news, due to the day trading speculators, I still think we will see a pop, though as you say, it will require positive results.
News 
Market Data 
Discover 
